Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kit S Lam

Showing results (211-220 of 267) with videos related to

Pageof 27
Sort By:
Neurobiology of Aging|November 22, 2008
Candidate anti-A beta fluorene compounds selected from analogs of amyloid imaging agentsHyun-Seok Hong, Izumi Maezawa, Madhu Budamagunta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodiesPatrick S C Leung, Chao Quan, Ogyi Park, et al.
Journal of Neurochemistry|October 24, 2007
Congo red and thioflavin-T analogs detect Abeta oligomersIzumi Maezawa, Hyun-Seok Hong, Ruiwu Liu, et al.
Molecular & Cellular Proteomics : MCP|July 19, 2006
A serum glycomics approach to breast cancer biomarkersCrystal Kirmiz, Bensheng Li, Hyun Joo An, et al.
Molecular Pharmacology|August 18, 2012
Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirsWenchang Guo, Ruiwu Liu, Yoko Ono, et al.
Molecular Cancer Therapeutics|September 23, 2010
The use of one-bead one-compound combinatorial library technology to discover high-affinity αvβ3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handleWenwu Xiao, Yan Wang, Edmond Y Lau, et al.
EJNMMI Research|February 29, 2016
Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumorsWenwu Xiao, Tianhong Li, Fernanda C Bononi, et al.
Journal of Autoimmunity|August 1, 2006
Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosisRoman Rieger, Patrick S C Leung, Melissa R Jeddeloh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversibleKatsushi Amano, Patrick S C Leung, Qingchai Xu, et al.
ACS Nano|December 17, 2020
Tumor Receptor-Mediated In Vivo Modulation of the Morphology, Phototherapeutic Properties, and Pharmacokinetics of Smart NanomaterialsLu Zhang, Yi Wu, Xingbin Yin, et al.
Pageof 27

Showing results (211-220 of 267) with videos related to

Sort By:
Pageof 27
Neurobiology of Aging|November 22, 2008
Candidate anti-A beta fluorene compounds selected from analogs of amyloid imaging agentsHyun-Seok Hong, Izumi Maezawa, Madhu Budamagunta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodiesPatrick S C Leung, Chao Quan, Ogyi Park, et al.
Journal of Neurochemistry|October 24, 2007
Congo red and thioflavin-T analogs detect Abeta oligomersIzumi Maezawa, Hyun-Seok Hong, Ruiwu Liu, et al.
Molecular & Cellular Proteomics : MCP|July 19, 2006
A serum glycomics approach to breast cancer biomarkersCrystal Kirmiz, Bensheng Li, Hyun Joo An, et al.
Molecular Pharmacology|August 18, 2012
Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirsWenchang Guo, Ruiwu Liu, Yoko Ono, et al.
Molecular Cancer Therapeutics|September 23, 2010
The use of one-bead one-compound combinatorial library technology to discover high-affinity αvβ3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handleWenwu Xiao, Yan Wang, Edmond Y Lau, et al.
EJNMMI Research|February 29, 2016
Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumorsWenwu Xiao, Tianhong Li, Fernanda C Bononi, et al.
Journal of Autoimmunity|August 1, 2006
Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosisRoman Rieger, Patrick S C Leung, Melissa R Jeddeloh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversibleKatsushi Amano, Patrick S C Leung, Qingchai Xu, et al.
ACS Nano|December 17, 2020
Tumor Receptor-Mediated In Vivo Modulation of the Morphology, Phototherapeutic Properties, and Pharmacokinetics of Smart NanomaterialsLu Zhang, Yi Wu, Xingbin Yin, et al.
Pageof 27